VivoSim Stock Sits Near 52-Week Low, Biotech Faces Pre-Market Cash Crunch
VivoSim Labs slipped in early pre-market trade Tuesday, last quoted at $1.29, off around 0.8%. The drug-testing microcap is trading just above its 52-week low of $1.22, with a market cap near $3.36 million. That small move stands out since biotech was weak before the bell. The SPDR S&P Biotech ETF was off 2.2% in the latest trading. The iShares Nasdaq Biotechnology ETF lost 1.6%. That drop adds pressure, especially on smaller stocks where trading is light.